Adage Capital Partners
IDIX

Adage Capital Partners’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Adage Capital Partners’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,182,107
Closed -$28.5M – 790
2014
Q2 		$28.5M Hold
1,182,107
– – 0.07% 313
2014
Q1 		$7.13M Hold
1,182,107
– – 0.02% 553
2013
Q4 		$7.07M Sell
1,182,107
-150,000
-11% -$694K 0.02% 558
2013
Q3 		$6.91M Sell
1,332,107
-200,000
-13% -$876K 0.02% 547
2013
Q2 		$5.53M Buy
+1,532,107
New +$6.27M 0.02% 582

Adage Capital Partners's IDIX Position: Q3 2014 in Review

Adage Capital Partners sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 1,182,107 shares — an estimated $28.5M sold.

Adage Capital Partners first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $28.5M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Adage Capital Partners reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Adage Capital Partners sold 1,182,107 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $28.5M.
  • Adage Capital Partners first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Adage Capital Partners's IDENIX PHARMACEUTICALS INC position peaked at $28.5M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Adage Capital Partners's 13F filing for Q3 2014, filed 14 Nov 2014.